Retractable Technologies, Inc. RVP, a leading maker of
safety medical devices, announced today that a Tyler, Texas jury
returned a verdict in the litigation of Retractable Technologies, Inc.
v. Becton, Dickinson and Company BDX in favor of Retractable. After a six
year battle, the verdict vindicates Retractable's claim that industry
giant Becton, Dickinson and Company illegally engaged in anticompetitive
conduct with the intent to acquire or maintain monopoly power in the
safety syringe market and engaged in false advertising under the Lanham
Act. The jury awarded Retractable $113,508,014 in compensatory damages
subject to being trebled pursuant to federal statute. Retractable is
represented by Locke Lord LLP; Ireland, Carroll & Kelley, P.C.; and Jim
Parsons Law.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in